An anticholinergic reverses motor control and corticostriatal LTD deficits in Dyt1 ΔGAG knock-in mice

Behavioural Brain Research

Volumn 226, Issue 2, 2012, Pages 465-472

  Dang, Mai T ^a   Yokoi, Fumiaki ^b   Cheetham, Chad C ^c   Lu, Jun ^c   Vo, Viet ^d   Lovinger, David M ^e   Li, Yuqing ^b  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^e NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

Author keywords

Dopamine receptor; Dystonia; Long term depression; TorsinA; Trihexyphenidyl

Indexed keywords

4 (2 BENZYLBENZOYL) 2,5 DIMETHYL 1H PYRROLE 3 CARBOXYLIC ACID METHYL ESTER; BRAIN PROTEIN; CHOLINERGIC RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR; MESSENGER RNA; MUSCARINIC RECEPTOR; TORSINA PROTEIN; TRIHEXYPHENIDYL; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICHOLINERGIC EFFECT; ARTICLE; BEAM WALKING TEST; CELL COMMUNICATION; CONTROLLED STUDY; CORPUS STRIATUM; DENDRITE; DYSTONIA; ELECTRIC POTENTIAL; ELECTROPHYSIOLOGY; EXPERIMENTAL TEST; GENE DELETION; INTERNEURON; LONG TERM DEPRESSION; MALE; MOTOR CONTROL; MOUSE; NERVE CELL PLASTICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BINDING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPIKE WAVE;

ANIMALS; CALCIUM CHANNEL AGONISTS; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; DYSTONIA MUSCULORUM DEFORMANS; GENE KNOCK-IN TECHNIQUES; HUMANS; LONG-TERM POTENTIATION; LONG-TERM SYNAPTIC DEPRESSION; MALE; MICE; MICE, TRANSGENIC; MOLECULAR CHAPERONES; MUSCARINIC ANTAGONISTS; PYRROLES; RECEPTORS, DOPAMINE D2; TRIHEXYPHENIDYL;

EID: 81355146404     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2011.10.002     Document Type: Article

References (52)

1. Rostasy K., Augood S.J., Hewett J.W., Leung J.C., Sasaki H., Ozelius L.J., et al. TorsinA protein and neuropathology in early onset generalized dystonia with GAG deletion. Neurobiol Dis 2003, 12:11-24.
2. Fahn S. The genetics of idiopathic torsion dystonia. Int J Neurol 1991, 25-26:70-80.
3. Ozelius L.J., Hewett J.W., Page C.E., Bressman S.B., Kramer P.L., Shalish C., et al. The early-onset torsion dystonia gene (DYT1) encodes an ATP-binding protein. Nat Genet 1997, 17:40-48.
4. Leung J.C., Klein C., Friedman J., Vieregge P., Jacobs H., Doheny D., et al. Novel mutation in the TOR1A (DYT1) gene in atypical early onset dystonia and polymorphisms in dystonia and early onset parkinsonism. Neurogenetics 2001, 3:133-143.
5. Ogura T., Wilkinson A.J. AAA+ superfamily ATPases: common structure-diverse function. Genes Cells 2001, 6:575-597.
6. Augood S.J., Penney J.B., Friberg I.K., Breakefield X.O., Young A.B., Ozelius L.J., et al. Expression of the early-onset torsion dystonia gene (DYT1) in human brain. Ann Neurol 1998, 43:669-673.
7. Dang M.T., Yokoi F., McNaught K.S., Jengelley T.A., Jackson T., Li J., et al. Generation and characterization of Dyt1 deltaGAG knock-in mouse as a model for early-onset dystonia. Exp Neurol 2005, 196:452-463.
8. Balcioglu A., Kim M.O., Sharma N., Cha J.H., Breakefield X.O., Standaert D.G. Dopamine release is impaired in a mouse model of DYT1 dystonia. J Neurochem 2007, 102:783-788.
9. Bao L., Patel J.C., Walker R.H., Shashidharan P., Rice M.E. Dysregulation of striatal dopamine release in a mouse model of dystonia. J Neurochem 2010, 114:1781-1791.
10. Asanuma K., Ma Y., Okulski J., Dhawan V., Chaly T., Carbon M., et al. Decreased striatal D2 receptor binding in non-manifesting carriers of the DYT1 dystonia mutation. Neurology 2005, 64:347-349.
11. 18F]spiperone binding in putamen in idiopathic focal dystonia. J Neurosci 1997, 17:843-850.
12. McNaught K.S., Kapustin A., Jackson T., Jengelley T.A., Jnobaptiste R., Shashidharan P., et al. Brainstem pathology in DYT1 primary torsion dystonia. Ann Neurol 2004, 56:540-547.
13. Goodchild R.E., Kim C.E., Dauer W.T. Loss of the dystonia-associated protein torsinA selectively disrupts the neuronal nuclear envelope. Neuron 2005, 48:923-932.
14. Hewett J.W., Tannous B., Niland B.P., Nery F.C., Zeng J., Li Y., et al. Mutant torsinA interferes with protein processing through the secretory pathway in DYT1 dystonia cells. Proc Natl Acad Sci USA 2007, 104:7271-7276.
15. Kustedjo K., Bracey M.H., Cravatt B.F. Torsin A and its torsion dystonia-associated mutant forms are lumenal glycoproteins that exhibit distinct subcellular localizations. J Biol Chem 2000, 275:27933-27939.
16. Quartarone A., Bagnato S., Rizzo V., Siebner H.R., Dattola V., Scalfari A., et al. Abnormal associative plasticity of the human motor cortex in writer's cramp. Brain 2003, 126:2586-2596.
17. Weise D., Schramm A., Stefan K., Wolters A., Reiners K., Naumann M., et al. The two sides of associative plasticity in writer's cramp. Brain 2006, 129:2709-2721.
18. Hallett M. Neurophysiology of dystonia: the role of inhibition. Neurobiol Dis 2011, 42:177-184.
19. Huang Y.Z., Edwards M.J., Rounis E., Bhatia K.P., Rothwell J.C. Theta burst stimulation of the human motor cortex. Neuron 2005, 45:201-206.
20. Sohn Y.H., Hallett M. Surround inhibition in human motor system. Exp Brain Res 2004, 158:397-404.
21. Mink J.W. The Basal Ganglia and involuntary movements: impaired inhibition of competing motor patterns. Arch Neurol 2003, 60:1365-1368.
22. Quartarone A., Pisani A. Abnormal plasticity in dystonia: disruption of synaptic homeostasis. Neurobiol Dis 2011, 42:162-170.
23. Yokoi F., Dang M.T., Miller C.A., Marshall A.G., Campbell S.L., Sweatt J.D., et al. Increased c-fos expression in the central nucleus of the amygdala and enhancement of cued fear memory in Dyt1 DeltaGAG knock-in mice. Neurosci Res 2009, 65:228-235.
24. Laforet G.A., Sapp E., Chase K., McIntyre C., Boyce F.M., Campbell M., et al. Changes in cortical and striatal neurons predict behavioral and electrophysiological abnormalities in a transgenic murine model of Huntington's disease. J Neurosci 2001, 21:9112-9123.
25. Partridge J.G., Tang K.C., Lovinger D.M. Regional and postnatal heterogeneity of activity-dependent long-term changes in synaptic efficacy in the dorsal striatum. J Neurophysiol 2000, 84:1422-1429.
26. Yin H.H., Park B.S., Adermark L., Lovinger D.M. Ethanol reverses the direction of long-term synaptic plasticity in the dorsomedial striatum. Eur J Neurosci 2007, 25:3226-3232.
27. Dang M.T., Yokoi F., Yin H.H., Lovinger D.M., Wang Y., Li Y. Disrupted motor learning and long-term synaptic plasticity in mice lacking NMDAR1 in the striatum. Proc Natl Acad Sci USA 2006, 103:15254-15259.
28. Franklin K.B.J., Paxinos G. The mouse brain in stereotaxic coordinates 2008, Elsevier Inc., San Diego.
29. Benn C.L., Farrell L.A., Cha J.H. Neurotransmitter receptor analysis in transgenic mouse models. Methods Mol Biol 2004, 277:231-260.
30. 3H]raclopride for dopamine d-2 receptor binding to rat striatum. Eur J Pharmacol 1989, 173:177-182.
31. Giordano T.P., Satpute S.S., Striessnig J., Kosofsky B.E., Rajadhyaksha A.M. Up-regulation of dopamine D(2)L mRNA levels in the ventral tegmental area and dorsal striatum of amphetamine-sensitized C57BL/6 mice: role of Ca(v)1.3 L-type Ca(2+) channels. J Neurochem 2006, 99:1197-1206.
32. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001, 25:402-408.
33. Jinnah H.A., Sepkuty J.P., Ho T., Yitta S., Drew T., Rothstein J.D., et al. Calcium channel agonists and dystonia in the mouse. Mov Disord 2000, 15:542-551.
34. Yokoi F., Dang M.T., Li J., Li Y. Myoclonus, motor deficits, alterations in emotional responses and monoamine metabolism in epsilon-sarcoglycan deficient mice. J Biochem 2006, 140:141-146.
35. Calabresi P., Maj R., Pisani A., Mercuri N.B., Bernardi G. Long-term synaptic depression in the striatum: physiological and pharmacological characterization. J Neurosci 1992, 12:4224-4233.
36. Choi S., Lovinger D.M. Decreased probability of neurotransmitter release underlies striatal long-term depression and postnatal development of corticostriatal synapses. Proc Natl Acad Sci USA 1997, 94:2665-2670.
37. 2+ channels and synaptic transmission is sufficient to induce striatal long-term depression. J Neurosci 2007, 27:6781-6787.
38. Wang Z., Kai L., Day M., Ronesi J., Yin H.H., Ding J., et al. Dopaminergic control of corticostriatal long-term synaptic depression in medium spiny neurons is mediated by cholinergic interneurons. Neuron 2006, 50:443-452.
39. Bonsi P., Martella G., Cuomo D., Platania P., Sciamanna G., Bernardi G., et al. Loss of muscarinic autoreceptor function impairs long-term depression but not long-term potentiation in the striatum. J Neurosci 2008, 28:6258-6263.
40. Martella G., Tassone A., Sciamanna G., Platania P., Cuomo D., Viscomi M.T., et al. Impairment of bidirectional synaptic plasticity in the striatum of a mouse model of DYT1 dystonia: role of endogenous acetylcholine. Brain 2009, 132:2336-2349.
41. Napolitano F., Pasqualetti M., Usiello A., Santini E., Pacini G., Sciamanna G., et al. Dopamine D2 receptor dysfunction is rescued by adenosine A2A receptor antagonism in a model of DYT1 dystonia. Neurobiol Dis 2010, 38:434-445.
42. Sharma N., Baxter M.G., Petravicz J., Bragg D.C., Schienda A., Standaert D.G., et al. Impaired motor learning in mice expressing torsinA with the DYT1 dystonia mutation. J Neurosci 2005, 25:5351-5355.
43. Zhao Y., DeCuypere M., LeDoux M.S. Abnormal motor function and dopamine neurotransmission in DYT1 DeltaGAG transgenic mice. Exp Neurol 2008, 210:719-730.
44. Dang M.T., Yokoi F., Pence M.A., Li Y. Motor deficits and hyperactivity in Dyt1 knockdown mice. Neurosci Res 2006, 56:470-474.
45. Calabresi P., Centonze D., Gubellini P., Pisani A., Bernardi G. Acetylcholine-mediated modulation of striatal function. Trends Neurosci 2000, 23:120-126.
46. Malenka R.C., Bear M.F. LTP and LTD: an embarrassment of riches. Neuron 2004, 44:5-21.
47. Yin H.H., Mulcare S.P., Hilario M.R., Clouse E., Holloway T., Davis M.I., et al. Dynamic reorganization of striatal circuits during the acquisition and consolidation of a skill. Nat Neurosci 2009, 12:333-341.
48. Smolders I., Bogaert L., Ebinger G., Michotte Y. Muscarinic modulation of striatal dopamine, glutamate, and GABA release, as measured with in vivo microdialysis. J Neurochem 1997, 68:1942-1948.
49. Torres G.E., Sweeney A.L., Beaulieu J.M., Shashidharan P., Caron M.G. Effect of torsinA on membrane proteins reveals a loss of function and a dominant-negative phenotype of the dystonia-associated DeltaE-torsinA mutant. Proc Natl Acad Sci USA 2004, 101:15650-15655.
50. Free R.B., Hazelwood L.A., Cabrera D.M., Spalding H.N., Namkung Y., Rankin M.L., et al. D1 and D2 dopamine receptor expression is regulated by direct interaction with the chaperone protein calnexin. J Biol Chem 2007, 282:21285-21300.
51. Naismith T.V., Dalal S., Hanson P.I. Interaction of torsinA with its major binding partners is impaired by the dystonia-associated DeltaGAG deletion. J Biol Chem 2009, 284:27866-27874.
52. Zhao Y., Sharma N., LeDoux M.S. The DYT1 carrier state increases energy demand in the olivocerebellar network. Neuroscience 2011, 177:183-194.